Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03275623 · ClinicalTrials.gov registry record · Phase 4
Management of Sub-Clinical Bacteriuria in Pregnancy
A Phase 4 study of Pyelonephritis and Cystitis, sponsored by The University of Texas Health Science Center, Houston.
- Completed
- Registry status
- Phase 4
- Development phase
- 60
- Enrollment target
- 1
- Study location
NCT03275623 is a Phase 4 study of Pyelonephritis and Cystitis that has completed, run by The University of Texas Health Science Center, Houston. The registered enrollment target is 60 participants. The trial reports 1 study location across 1 state.
The verdict
NCT03275623, a Phase 4 study of Pyelonephritis and Cystitis, has completed, sponsored by The University of Texas Health Science Center, Houston.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 60 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of the study is to determine if treatment of pregnant women with urine cultures with a low level of bacteria (less than 100,000 colony forming units (CFU)) may decrease adverse pregnancy outcomes.
Conditions Studied
Interventions
- DRUG Antibiotic
- OTHER Standard Prenatal Care
Study Locations (1)
Texas
- The University of Texas Health Science Center at Houston - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2017-09-15 |
| Est. Completion | 2019-03-18 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03275623
The ClinicalTrials.gov registry entry for NCT03275623 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The University of Texas Health Science Center, Houston, which has 732 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Pyelonephritis appearing as the primary indexed condition, and to 2 interventions - of which Antibiotic is the first listed.
NCT03275623 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.
Frequently Asked Questions
What is clinical trial NCT03275623 about?
NCT03275623 is a clinical study titled "Management of Sub-Clinical Bacteriuria in Pregnancy". The purpose of the study is to determine if treatment of pregnant women with urine cultures with a low level of bacteria (less than 100,000 colony forming units (CFU)) may decrease adverse pregnancy outcomes.
What is the current status of trial NCT03275623?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 60 participants. The study started on 2017-09-15. Estimated completion is 2019-03-18.
What conditions does trial NCT03275623 study?
This clinical trial studies the following conditions: Pyelonephritis, Cystitis, Cystitis;Puerperium.
What interventions are being tested in trial NCT03275623?
The interventions under investigation include: Antibiotic (DRUG), Standard Prenatal Care (OTHER).
Who is sponsoring clinical trial NCT03275623?
This trial is sponsored by The University of Texas Health Science Center, Houston, which has 732 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03275623 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pyelonephritis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.